...
首页> 外文期刊>The American surgeon. >Clinical Outcomes after Surgery for Linitis Plastica of the Stomach: Analysis of a Population Cancer Registry
【24h】

Clinical Outcomes after Surgery for Linitis Plastica of the Stomach: Analysis of a Population Cancer Registry

机译:胃窦素塑料术后临床结果:人口癌症登记分析

获取原文
获取原文并翻译 | 示例
           

摘要

Linitis plastica (LP), a subset of gastric adenocarcinoma (GA), has been considered as a fatal disease with few management options. Little evidence has been reported regarding the role for surgical therapy in treating LP. A retrospective review of GA patients with LP from the surveillance, epidemiology, and end results database (2004-2009) was performed. 29,440 patients with GA were identified, of whom 948 (3.2%) had LP. After matching for American Joint Commission on Cancer (AJCC) stage, LP patients had significantly worse 5-year disease specific survival (DSS) compared with GA (6 vs 34%, P < 0.001). For potentially resectable LP patients (i.e., stage I-III), 5-year DSS was 0 per cent for no treatment and for radiation therapy alone, 18 per cent for both and surgery and radiation, and 20 per cent for surgery alone(P < 0.001). LP is a marker of poor survival in patients with GA. However, surgical resection provides the best oncologic outcomes in these patients with a 20 per cent 5-year DSS in patients with loco-regional disease.
机译:胃窦炎素(LP)是一种胃腺癌(GA)的子集,已被认为是具有少数管理选择的致命疾病。据报道,关于手术治疗液化LP的作用,据报道少数证据。对来自监测,流行病学和最终结果数据库(2004-2009)的LP患者的回顾性审查。鉴定了29,440例GA患者,其中948名(3.2%)有LP。与美国联合癌症联合委员会(AJCC)阶段匹配后,LP患者与GA(6 vs 34%,P <0.001)相比,LP患者的5年疾病特异性存活率(DSS)明显差。对于潜在的LP患者(即阶段I-III),5年的DSS为0%,无需治疗和单独的放射治疗,既%和手术和辐射为18%,单独服用20%(P <0.001)。 LP是GA患者存活率不佳的标记。然而,手术切除术在这些患者中提供了最佳的肿瘤结果,患有型患者的患者为20%的DSS,患者患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号